CPSC recall 21719 — Scalpa Recalls Scalpa Numb Maximum Strength Topical Anesthetic Cream Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

Scalpa Recalls Scalpa Numb Maximum Strength Topical Anesthetic Cream Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

CPSC · 21719 · published 2021-01-14

CPSC campaign 21719

Hazard

The product contains the substance lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of poisoning to young children.

Remedy

Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a safe location out of reach of children and contact Scalpa for a full refund or store credit. Scalpa is directly notifying all known purchasers about the recall.

The text above is quoted verbatim from the CPSC record. Confirm the affected units and the remedy with the manufacturer or CPSC. Recall data may be incomplete, delayed, or superseded.

Own something like this?

Track your items and we’ll tell you the moment a recall covers one — free, forever.

Track an item like this

Affected products

Scalpa Inc., of Phoenix, Ariz.

Scalpa Numb Maximum Strength Topical Anesthetic Cream

Scalpa Inc., of Phoenix, Ariz.

UPC 857076008689

Scalpa Recalls Scalpa Numb Maximum Strength Topical Anesthetic Cream Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

Affected products

Brands in this recall